AOD-9604 5mg

Description

AOD-9604 5mg – Research Peptide

AOD-9604 5mg is a high-purity, research-grade peptide supplied for controlled laboratory investigation involving peptide signaling pathways, molecular peptide structure, and biochemical pathway analysis.

AOD-9604 represents a synthetic peptide fragment derived from the C-terminal region of the human growth hormone molecule. Within scientific literature, this peptide corresponds to amino acids 176-191 of the growth hormone sequence.

This peptide fragment has been referenced in research discussions involving receptor signalling models, peptide-receptor interactions, and biochemical regulatory pathways studied within controlled experimental environments.

AOD-9604 5mg is supplied strictly for in-vitro laboratory research and analytical investigation. This compound is not approved for human or veterinary use.

What Is AOD-9604?

AOD-9604 is a synthetic peptide fragment corresponding to amino acids 176-191 of the human growth hormone sequence.

This fragment has been examined in research literature exploring peptide signaling models, molecular pathway activity, and peptide interaction mechanisms studied within laboratory research settings.

Unlike the full growth hormone molecule, AOD-9604 represents a smaller peptide sequence that has been isolated and studied independently within experimental peptide research frameworks.

Published scientific literature referencing AOD-9604 commonly discusses experimental topics involving peptide signaling mechanisms and molecular pathway analysis.

Areas referenced in research literature include:

• Peptide signaling pathway models
• Molecular interactions involving growth hormone fragments
• Biochemical pathway analysis involving receptor signalling
• Peptide stability and structural analysis
• Molecular mechanisms involving peptide fragments derived from growth hormone
• Molecular activity of growth hormone peptide fragments
• Peptide-receptor interaction analysis
• Receptor pathway signaling models in laboratory environments
• Structural peptide fragment studies

These areas remain topics of ongoing laboratory research and scientific investigation.

AOD-9604 5mg – Research Supply Specifications

• Synthetic research peptide
• 5mg lyophilized peptide per vial
• Analytical purity standard: 99%+
• Third-party laboratory testing for identity and purity
• Manufactured under controlled quality standards
• Canada-based fulfillment
• Batch-level quality verification

Purity & Quality Assurance

ExoLabz provides research peptides manufactured to high analytical standards. ExoLabz products undergo independent third-party testing to verify peptide identity and purity. Results are published on this site.

Researchers may conduct additional analytical verification if required for laboratory use. If validated testing confirms a verified purity discrepancy, ExoLabz provides refund and testing reimbursement in accordance with company policy.

Important Legal Notice

For Research Purposes Only

AOD-9604 5mg is supplied strictly for laboratory research and analytical use.

This compound is not intended for human consumption, veterinary use, clinical research involving human subjects, therapeutic use, or diagnostic applications.

This product has not been evaluated or approved by Health Canada, the U.S. Food and Drug Administration (FDA), or any other regulatory authority.

By purchasing this product, the buyer confirms that the material will be handled only by qualified professionals and used solely for lawful laboratory research purposes.

Compound identity and specification

Identity data for AOD-9604, published so the material can be checked against an independent record rather than taken on trust. The formula, mass and registry number below are verified against PubChem and can be looked up directly.

Analytical note — AOD-9604. A 16-residue construct: a tyrosine added to the hGH(177-191) fragment, which is why the tyrosine is there at all – it gives the molecule a 280 nm chromophore the bare fragment would lack. It contains a disulfide bridge, so a reduced form of about 2 Da higher mass is a possible related substance.

Identity references The molecular formula, molecular mass and CAS registry number above are taken from the PubChem record linked in the table, not from a supplier datasheet, so every figure can be checked against an independent source in one click. Sequences are given as reported in the peptide literature, in the one-letter or three-letter convention as appropriate, with any non-standard residue named in full. Where a compound exists in more than one form — a free peptide and a metal complex, a fragment and its parent protein, a modified and an unmodified analog — the form supplied is the one identified here, and the mass on the certificate of analysis is what distinguishes it.

Research Literature

Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.

• Heffernan M, et al. Endocrinology. 2001;142(12):5182-5189. In wild-type and beta3-adrenergic receptor knockout mice, measured beta3-AR mRNA expression, establishing receptor dependency. Source · PMID 11713213
• Ng FM, et al. Horm Res. 2000;53(6):274-278. In a Zucker rat model, characterised ex vivo receptor-pathway activity; see the linked record for methods and endpoints. Source · PMID 11146367

Literature notes: Papers concerning the related analog AOD-9401 are sometimes miscited as AOD-9604 work; the references above concern AOD-9604 specifically.

The third-party report for this material is published on this page, and every certificate we hold is collected on the certificates of analysis page.

Related Research Compounds

Browse more compounds in GHS, or view the full research peptide catalogue.

• TESAMORELIN 10mg
• CJC-1295 (NO DAC) 5mg
• IPAMORELIN 10mg
• SERMORELIN 10mg